Oneness Biotech Co., Ltd. - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Oneness Biotech Co., Ltd. - Depositary Receipt (Common Stock)
LU ˙ BDL
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Oneness Biotech Co., Ltd. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 39 42 49 30 52 66 75 1,079 1,069 1,066 1,068 71 76 87 90 102 112 118 117 113
Change (%) 6.07 18.59 -38.38 72.04 25.73 13.84 1,341.20 -0.93 -0.32 0.20 -93.38 7.32 14.36 4.17 12.74 10.07 5.11 -0.50 -4.06
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 9 11 12 11 19 21 30 215 215 221 219 45 48 54 52 53 49 55 63 72
Change (%) 20.50 6.42 -3.31 69.29 9.25 43.33 622.73 0.34 2.69 -0.80 -79.46 7.45 11.99 -3.47 0.83 -6.92 11.75 15.35 14.37
% of Revenue 23.04 26.17 23.48 36.85 36.26 31.51 39.67 19.89 20.15 20.76 20.55 63.72 63.80 62.48 57.90 51.78 43.78 46.55 53.96 64.33
Gross Operating Profit 30 31 38 19 33 45 45 864 854 844 848 26 27 33 38 49 63 63 54 40
Change (%) 1.76 22.91 -49.14 73.64 35.10 0.28 1,813.60 -1.24 -1.08 0.46 -96.98 7.10 18.53 16.90 29.13 28.33 -0.07 -14.31 -25.66
% of Revenue 76.96 73.83 76.52 63.15 63.74 68.49 60.33 80.11 79.85 79.24 79.45 36.28 36.20 37.52 42.10 48.22 56.22 53.45 46.04 35.67
SG&A 108 108 107 103 105 117 133 152 168 167 176 172 166 177 180 198 220 224 225 222
Change (%) -0.13 -0.29 -4.33 2.56 11.40 13.38 14.48 10.67 -0.93 5.41 -2.37 -3.45 6.57 1.63 10.22 11.14 1.65 0.55 -1.40
% of Revenue 274.54 258.50 217.33 337.42 201.16 178.25 177.52 14.10 15.75 15.66 16.47 242.79 218.42 203.54 198.58 194.14 196.02 189.57 191.57 196.87
R&D 518 589 727 695 791 806 739 791 854 919 940 979 952 953 965 959 980 925 845 776
Change (%) 13.78 23.40 -4.38 13.76 1.89 -8.32 7.03 8.01 7.60 2.32 4.09 -2.75 0.08 1.32 -0.64 2.19 -5.62 -8.68 -8.15
% of Revenue 1,320.49 1,416.37 1,473.78 2,286.85 1,512.20 1,225.52 986.92 73.29 79.90 86.25 88.07 1,384.19 1,254.31 1,097.62 1,067.50 940.83 873.44 784.30 719.87 689.17
OpEx 642 715 853 809 915 944 901 1,158 1,238 1,307 1,336 1,195 1,166 1,183 1,197 1,210 1,250 1,204 1,133 1,070
Change (%) 11.39 19.35 -5.15 13.11 3.14 -4.49 28.41 6.94 5.58 2.18 -10.49 -2.47 1.49 1.14 1.11 3.26 -3.65 -5.86 -5.61
% of Revenue 1,636.07 1,718.01 1,728.90 2,661.12 1,749.63 1,435.27 1,204.11 107.29 115.80 122.66 125.09 1,690.70 1,536.52 1,363.64 1,323.97 1,187.36 1,113.80 1,020.96 965.94 950.37
Operating Income -602 -673 -804 -779 -863 -878 -827 -79 -169 -241 -268 -1,125 -1,090 -1,097 -1,107 -1,108 -1,137 -1,086 -1,016 -957
Change (%) 11.73 19.39 -3.11 10.81 1.77 -5.87 -90.49 114.84 42.97 10.94 319.90 -3.08 0.60 0.90 0.16 2.63 -4.52 -6.45 -5.78
% of Revenue -1,536.07 -1,618.01 -1,628.90 -2,561.12 -1,649.63 -1,335.27 -1,104.11 -7.29 -15.80 -22.66 -25.09 -1,590.70 -1,436.52 -1,263.64 -1,223.97 -1,087.36 -1,013.80 -920.96 -865.94 -850.37
Interest Expense -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -5 -6 -7 -8 -10 -10 -9 -9
Change (%) -4.73 -1.49 -1.63 -0.78 -1.61 -1.33 -1.39 -2.41 -1.23 -0.94 -0.75 -0.31 24.56 23.53 19.13 15.32 0.92 -2.15 -1.67
% of Revenue -13.86 -12.45 -10.34 -16.50 -9.52 -7.45 -6.46 -0.44 -0.44 -0.43 -0.43 -6.39 -5.94 -6.46 -7.67 -8.10 -8.49 -8.15 -8.01 -8.21
Net Income 156 -242 64 -901 -1,099 -403 -132 679 1,131 360 -293 -967 -1,469 -1,313 -1,141 -979 -1,259 -1,165 -1,235 -1,906
Change (%) -254.81 -126.66 -1,496.65 22.04 -63.31 -67.28 -614.77 66.47 -68.16 -181.46 229.75 51.94 -10.64 -13.11 -14.19 28.58 -7.43 5.98 54.33
% of Revenue 398.38 -581.42 130.69 -2,962.07 -2,101.23 -613.25 -176.25 62.95 105.78 33.78 -27.47 -1,367.55 -1,936.15 -1,512.82 -1,261.87 -960.39 -1,121.83 -988.03 -1,052.43 -1,692.91

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista